"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Descriptor ID |
D009154
|
MeSH Number(s) |
G05.365.590
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 14 | 26 | 40 |
1996 | 14 | 18 | 32 |
1997 | 17 | 37 | 54 |
1998 | 23 | 24 | 47 |
1999 | 22 | 52 | 74 |
2000 | 19 | 53 | 72 |
2001 | 19 | 49 | 68 |
2002 | 22 | 68 | 90 |
2003 | 34 | 74 | 108 |
2004 | 33 | 75 | 108 |
2005 | 33 | 89 | 122 |
2006 | 27 | 83 | 110 |
2007 | 42 | 85 | 127 |
2008 | 38 | 71 | 109 |
2009 | 40 | 73 | 113 |
2010 | 33 | 80 | 113 |
2011 | 41 | 105 | 146 |
2012 | 47 | 92 | 139 |
2013 | 44 | 106 | 150 |
2014 | 74 | 114 | 188 |
2015 | 80 | 121 | 201 |
2016 | 83 | 106 | 189 |
2017 | 77 | 144 | 221 |
2018 | 79 | 144 | 223 |
2019 | 64 | 142 | 206 |
2020 | 45 | 175 | 220 |
2021 | 42 | 142 | 184 |
2022 | 4 | 129 | 133 |
2023 | 3 | 110 | 113 |
2024 | 34 | 91 | 125 |
2025 | 25 | 69 | 94 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenstr?m macroglobulinemia. Blood Adv. 2025 Oct 14; 9(19):4842-4847.
-
Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenstr?m macroglobulinemia: a pooled analysis. Blood Adv. 2025 Sep 23; 9(18):4705-4715.
-
Altered Gating of Two CaV2.1 Variants Linked to Neurodevelopmental Disorders With Epilepsy and Migraine. FASEB J. 2025 Sep 15; 39(17):e71012.
-
Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations. Sci Adv. 2025 Sep 12; 11(37):eadx3505.
-
Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA. Cancer Discov. 2025 Sep 04; 15(9):1794-1802.
-
Rbm8a deficiency causes hematopoietic defects by modulating Wnt/PCP signaling. Dev Biol. 2025 Dec; 528:34-56.
-
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis. Lancet Oncol. 2025 Sep; 26(9):1178-1190.
-
Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis. Nat Genet. 2025 Sep; 57(9):2215-2225.
-
TPI deficiency: A case report and review of the literature. Mol Genet Metab. 2025 Sep-Oct; 146(1-2):109227.
-
Somatic Mutations in MCOLN3 Are Associated With Aldosterone-Producing Adenomas. Hypertension. 2025 Oct; 82(10):1778-1788.